EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder
Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its benefits outweighed its risks.
Portugal will resume on Monday, Spain and the Netherlands next week, while Sweden’s public health agency said it would take “a few days” to decide.
Continue reading...from The Guardian https://ift.tt/3rZDgBX
